에스디생명공학
499KRWMarket close of 10/27 (Tue)
No trade that dayMarket close of 10/27 (Tue)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)499KRWFlat 0.00%
Preliminary · replaced once official KRX data for the same date is published
- Volume
- 0×10K shares
- 0 KRW
Open, high and low are not shown — the source has no bar for the reference date
Market close of 10/27 (Tue)
Where it sits in the 1-year range
0%0% of the way up from the lowest close in 1 year (252 sessions) · -91.0% from the high
Free · no sign-inSource from 2021-05-17
Points to check
- Daily moveto checkNo trades this day (0 shares)
- Earningsto check-5.7B KRWOperating income over the last four quarters -5.7B KRW (loss)
- Trading valuenot verifiedNo trading that day, so not compared with usual trading value
The other 2
- Recent filingsnot verified
- Foreign & institutionalnot verified
See the full check report
Quarterly results · Q2 2026
- Revenue6.3B KRW
- vs. year ago
- -19.3%
- vs. prior quarter
- +3.7%
- Operating income-1.4B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
- Operating margin-22.1%
- vs. year ago
- +1.9 pp
- vs. prior quarter
- -4.6 pp
Quarterly operating income trend
As of the latest official close · 2026-10-27Valuation filing date · 2026-08-07Same sector · 화학
Up +1.01%· 113 of 165 stocks up, preferred shares excluded · trading value 518.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 한화솔루션 | Close over the last 20 sessions -11.5% | Down -2.45% | 67.5B KRW |
| 에이피알 | Close over the last 20 sessions -24.6% | Down -1.42% | 56.0B KRW |
| LG화학 | Close over the last 20 sessions -9.5% | Up +1.56% | 45.8B KRW |
| 원익홀딩스 | Close over the last 20 sessions -16.1% | Up +0.85% | 26.8B KRW |
| 코스맥스 | Close over the last 20 sessions -3.1% | Down -1.68% | 25.6B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 19 days
- Next data 10/29 (Thu) after 08:50
Related news
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.